Fact CheckerSign in

NCT06925841Completed

Psychosocial Effects of Coloring in Preeclamptic Pregnant Women

The Effect of Mother-Baby Themed Coloring on Stress, Anxiety, and Psychosocial Health in Pregnant Women Diagnosed With Preeclampsia: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 13 Apr 2025

Brief summary (registry, in English)

Preeclampsia is one of the major causes of maternal and neonatal mortality and morbidity, affecting approximately 3-5% of pregnancies. A diagnosis of preeclampsia may lead to psychological problems such as psychosocial distress, depression, and anxiety due to prolonged hospitalization, concerns about the future health of the baby, separation from family, and adapting to a foreign environment. Health professionals play a crucial role in the diagnosis, treatment, and care of high-risk pregnancies and also implement non-pharmacological supportive methods such as yoga, progressive muscle relaxation, and mindfulness. One of these non-pharmacological methods is mandala. According to the literature, integrating mandala coloring into perinatal care is believed to have beneficial effects. Therefore, the primary aim of this study is to investigate the effects of mother-baby themed coloring on anxiety. The secondary aim is to determine its effects on psychosocial health and cortisol levels. H1a: Is there a difference between anxiety scores in preeclamptic pregnant women who were and were not exposed to dyeing activity? H1b: Is there a difference between psychosocial health scores in preeclamptic pregnant women who were and were not exposed to dyeing activity? H1c: Is there a difference between cortisol levels in preeclamptic pregnant women who were and were not exposed to dyeing activity?

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
7 Apr 2025
Start date
29 Mar 2024
Primary completion date
15 Dec 2024
Lead sponsor
Necmettin Erbakan University
NCT number
NCT06925841

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 29 Mar 2024 to the primary completion date, 15 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving psychological counseling during the intervention

Other illness

  • Using psychiatric medication (self-report)

Other

  • Diagnosed with severe preeclampsia

Who the study is looking for

  • Having a single and healthy fetus
  • Gestational age ≥ 20 weeks
  • Diagnosed with preeclampsia by a physician
  • Not having a history of treated pregnancy

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Necmettin Erbakan University
Coordinator of this site? Confirm its status
KonyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.